Interview with Eric P. Van Der Veer, PhD
Eric P. Van Der Veer, PhD Chief Scientific Officer Hybridize Therapeutics  How did you become interested in the field of oligonucleotides? After years of highly fundamental research geared towards understanding how splice modulation mediated by RNA-binding proteins impacts cellular differentiation, I was challenged ...